Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
10.57
+0.24 (2.32%)
Nov 6, 2025, 1:22 PM EST - Market open
Exagen Market Cap
Exagen has a market cap or net worth of $232.58 million as of November 6, 2025. Its market cap has increased by 377.75% in one year.
Market Cap
232.58M
Enterprise Value
219.81M
1-Year Change
377.75%
Ranking
Category
Stock Price
$10.57
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $232.58M, an increase of 268.55%. That is a compound annual growth rate of 23.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 227.30M | 214.33% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 853.21B |
| Johnson & Johnson | 449.19B |
| AbbVie | 381.93B |
| UnitedHealth Group | 297.27B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 216.40B |
| Novo Nordisk | 215.64B |